ShareValue scores for PSH0.XETRA: Valuation 50, Quality 50, Growth 47, Health 39.

PSH0.XETRA
XETRA

Sernova Biotherapeutics Inc

€0.07(+6.50%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

3% to 16%
Valuation
50
Fair Value
Price vs Value
Quality
50
Moderate
Business Strength
Growth
47
Moderate
Revenue & Earnings
Health
39
Stressed
Financial Stability
Momentum
27
Bearish
Price Trend

Company Details

About

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026